Episode 219: COVID-19 Update Featuring Dr. David Parke II, and Dr. M. Ali Khan

Electron Microscopy of Coronavirus particles (yellow). From The National Institute of Allergy and Infectious Diseases' (NIAID) Rocky Mountains Laboratories (RML)

In this emergency podcast concerning the COVID-19 pandemic Dr. David Parke II, CEO of the American Academy of Ophthalmology, joins the program to answer the most common questions facing ophthalmologists today: what are the recommendations for protecting patients, staff, and physicians from COVID-19 exposure? What are the implications for the future? Then, Dr. M. Ali Khan and Jay discuss when COVID-19 felt like reality in the U.S. and the impact it has had on work and home life.

The AAO guidelines are here and will be continuously updated.

Financial disclosures: None relevant for any participant of this episode. Dr. Parke is the current CEO of the American Academy of Ophthalmology.

You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio